Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study

被引:35
|
作者
Obrosova, IG [1 ]
Fathallah, L [1 ]
机构
[1] Univ Michigan, Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Ann Arbor, MI 48109 USA
关键词
aldose reductase; ATPase activities; energy metabolism; lens; NAD(P)-redox state; oxidative stress; rat; reversal study; sorbinil; streptozotocin-diabetes;
D O I
10.1007/s001250051488
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Aldose reductase inhibitors (ARIs) prevent biochemical abnormalities associated with diabetic complications. We evaluated whether a short-term intervention with an adequate dose of ARI, introduced at the very early, precataractous stage, reversed diabetes-induced metabolic imbalances, down-regulation of ATPases and oxidative stress in the lens. Methods. The groups included mature control and streptozotocin-diabetic rats treated with or without ARI sorbinil (65 mg.kg(-1).day(-1), in the diet, for 2 weeks after 4 weeks of untreated diabetes). Free cytosolic NAD(+):NADH and NADP(+):NADPH ratios were calculated from the lactate dehydrogenase and malic enzyme systems. Concentrations of metabolites and adenine nucleotides, Na+/K+-ATPase, H+-ATPase and Ca++-independent Mg++-ATPase activities and variables of oxidative stress were measured in individual lenses. Results. Sorbinil treatment essentially corrected diabetes-induced sorbitol and fructose accumulation, myo-inositol depletion, decrease in free cytosolic NAD(+):NADH ratio and energy deficiency. Malondialdehyde accumulation, reduced glutathione depletion and the increase in oxidized glutathione:reduced glutathione ratio were partially corrected. Free cytosolic NADP(+):NADPH ratio and 4-hydroxyalkenal concentrations were similarly increased in diabetic rats treated with or without ARI. Sorbinil did not counteract diabetes-induced down-regulation of the three ATPase activities. Conclusion/interpretation. All biochemical changes assessed in our study are known to be prevented by ARIs. Despite the essential normalization of the sorbitol pathway activity, only part of them were, however, reversed by the ARI treatment introduced at the very early, i.e. precataractous, stage of diabetes. Therefore, intervention studies can easily underestimate the importance of aldose reductase in the pathogenesis of diabetic complications and should be interpreted with caution.
引用
收藏
页码:1048 / 1055
页数:8
相关论文
共 50 条
  • [1] Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study
    I. G. Obrosova
    L. Fathallah
    Diabetologia, 2000, 43 : 1048 - 1055
  • [2] Evaluation of an aldose reductase inhibitor on metabolism, ATP-ases and antioxidative defense in diabetic precataractous lens: An intervention study
    Fathallah, L
    Obrosova, IG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S215 - S215
  • [3] Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats
    Oya, M
    Hosokawa, M
    Tsukada, H
    Fukuda, K
    Nakamura, H
    Tsukiyama, K
    Nagashima, K
    Fujimoto, S
    Yamada, Y
    Semo, Y
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) : 69 - 77
  • [4] INTERVENTION WITH THE ALDOSE REDUCTASE INHIBITOR, TOLRESTAT, IN RENAL AND RETINAL LESIONS OF STREPTOZOTOCIN-DIABETIC RATS
    MCCALEB, ML
    MCKEAN, ML
    HOHMAN, TC
    LAVER, N
    ROBISON, WG
    DIABETOLOGIA, 1991, 34 (10) : 695 - 701
  • [5] EFFECTS OF ALDOSE REDUCTASE INHIBITOR ON RETINAL MICROANGIOPATHY IN STREPTOZOTOCIN-DIABETIC RATS
    KOJIMA, K
    MATSUBARA, H
    HARADA, T
    MIZUNO, K
    SUZUKI, M
    HOTTA, N
    KAKUTA, H
    SAKAMOTO, N
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1985, 29 (01) : 99 - 109
  • [6] IMPAIRED NERVE REGENERATION IN STREPTOZOTOCIN-DIABETIC RATS - EFFECTS OF TREATMENT WITH AN ALDOSE REDUCTASE INHIBITOR
    EKSTROM, PAR
    TOMLINSON, DR
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1989, 93 (2-3) : 231 - 237
  • [7] PREVENTION OF PERIPHERAL-NERVE DYSFUNCTION BY AN ALDOSE REDUCTASE INHIBITOR IN STREPTOZOTOCIN-DIABETIC RATS
    KIKKAWA, R
    HATANAKA, I
    YASUDA, H
    KOBAYASHI, N
    SHIGETA, Y
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1984, 33 (03): : 212 - 214
  • [8] THE EFFECTS OF LONG-TERM TREATMENT OF STREPTOZOTOCIN-DIABETIC RATS WITH AN ALDOSE REDUCTASE INHIBITOR
    POULSOM, R
    BOOTHANDFORD, RP
    HEATH, H
    EXPERIMENTAL EYE RESEARCH, 1983, 37 (05) : 507 - 515
  • [9] THE EFFECT OF INSULIN AND ALDOSE REDUCTASE INHIBITION ON THE PHOSPHATE-METABOLISM OF STREPTOZOTOCIN-DIABETIC RAT LENS
    CHENG, HM
    YOSHIDA, A
    XIONG, H
    GONZALEZ, RG
    EXPERIMENTAL EYE RESEARCH, 1991, 53 (06) : 805 - 808
  • [10] Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats
    Jiang, Yun
    Calcutt, Nigel A.
    Rames, Khara M.
    Mizisin, Andrew P.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2006, 11 (04) : 274 - 285